Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Neurofibromatosis 1 9Melanoma 6Neurofibroma, Plexiform 5Pancreatic Neoplasms 3Lung Neoplasms 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Thyroid Cancer, Papillary 2Sarcoma 2Neurofibrosarcoma 2Gallbladder Neoplasms 2Bile Duct Neoplasms 2Uveal Melanoma 1Thymoma 1Small Cell Lung Carcinoma 1Recurrence 1Peripheral Nervous System Diseases 1Non-small Cell Lung Cancer Metastatic 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neuroblastoma 1Neoplasms, Nerve Tissue 1Neoplasm Metastasis 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1

Interventions

Tretinoin 10Arsenic Trioxide 10Methotrexate 7Busulfan 7Gemtuzumab 6Cytarabine 6Cyclophosphamide 6Peripheral Blood Stem Cell Transplantation 5Filgrastim 5fludarabine phosphate 4Idarubicin 4Tacrolimus 3Etoposide 3Daunorubicin 3Antilymphocyte Serum 3lintuzumab 2Topotecan 2Radiotherapy 2Mycophenolic Acid 2Mercaptopurine 2Cyclosporins 2Cyclosporine 2Bortezomib 2Azacitidine 2thymoglobulin 1tamibarotene 1sargramostim 1romidepsin 1merphos 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Promyelocytic, Acute × AZD 6244 × Clear all
NCT00588809 2015-08-05

Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
47 enrolled 9 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡